2/20/2009

Acusphere has filed with the FDA an amendment to its new drug application for Imagify, recommending its use in certain groups of patients undergoing pharmacologic stress tests. The company also has successfully renegotiated the payment terms in some of its intellectual property contracts.

Full Story:
HealthImaging.com

Related Summaries